Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06167109 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NBI Combined With MRI to Guide CTV Optimization in Eccentric Nasopharyngeal Carcinoma

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 12, 2023 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
This is a prospective, single-center clinical trial in eccentric nasopharyngeal carcinoma (NPC) patients. The aim of this study is to evaluate the efficacy and safety of NBI combined with MRI-guided optimized CTV compared with conventional CTV, and to compare the radiotherapy-related adverse events and quality of life between the two groups.
Trial Details
NCT Number NCT06167109
Lead Sponsor Chongqing University Cancer Hospital
Conditions
(from sponsor)		 Nasopharyngeal Carcinoma by AJCC V8 Stage
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov